The Improved Experience You’ve Been Waiting For! Discover the refreshed menu, enjoy the custom dashboard, and make use of the powerful stock screener to enhance your investment approach. Explore Now

BNXT:CA BioNxt Solutions Inc. (formerly was XPHY/XPhyto Therapeutics Corp. until 2022-11-11)

CAD 0.21 0.00 ( 0)
Icon

BioNxt Solutions Inc. (formerly was XPHY/XPhyto Therapeutics Corp. until 2022-11-11) (BNXT:CA) Stock Analysis and Price Targets

COMMON STOCK | Drug Manufacturers - Specialty & Generic | CNSX
Target Add to Watchlist
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

CAD 0.21

0.00 (0.00)%

CAD 0.02B

0.04M

CAD -1.00

N/A
Icon

BNXT:CA

BioNxt Solutions Inc. (formerly was XPHY/XPhyto Therapeutics Corp. until 2022-11-11) (CAD)
COMMON STOCK | CNSX
CAD 0.21
0.00 ( 0)
Watchlist

BioNxt Solutions Inc. (formerly was XPHY/XPhyto Therapeutics Corp. until 2022-11-11) (BNXT:CA) Stock Forecast

CAD -1.00

Based on the BioNxt Solutions Inc. (formerly was XPHY/XPhyto Therapeutics Corp. until 2022-11-11) stock forecast from 0 analysts, the average analyst target price for BioNxt Solutions Inc. (formerly was XPHY/XPhyto Therapeutics Corp. until 2022-11-11) is not available over the next 12 months. BioNxt Solutions Inc. (formerly was XPHY/XPhyto Therapeutics Corp. until 2022-11-11)’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of BioNxt Solutions Inc. (formerly was XPHY/XPhyto Therapeutics Corp. until 2022-11-11) is Very Bearish, which is based on 0 positive signals and 2 negative signals. At the last closing, BioNxt Solutions Inc. (formerly was XPHY/XPhyto Therapeutics Corp. until 2022-11-11)’s stock price was CAD 0.21. BioNxt Solutions Inc. (formerly was XPHY/XPhyto Therapeutics Corp. until 2022-11-11)’s stock price has changed by +5.00% over the past week, -25.00% over the past month and 0% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date
Stock Target Advisor

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like